Who should join?

Industries and research organisations who are impacted by EU policy in these areas should consider membership of the association. 

Medical Devices Industry

The medical device industry has a great deal to gain from in silico medicine. Advances in modelling and simulation have led to development of more effective medical devices and the integration of software, devices and medicinal products require a holistic regulatory approach to their evaluation. 

Policies need to be created to ensure that modelling and simulation is used correctly so that the safest and most effective medical devices can be put on the market to the benefit of all.

Software Industry

A lack of framework for the validation of in silico models is a major barrier to those software industries engaged in healthcare. The Avicenna Alliance will work towards the creations of such a framework that would allow for maximum market uptake of medical software for pre-clinical and clinical use.

Data Protection and ensuring ease of access to health data for medical research purposes is a key priority of the Alliance.

Cosmetic Industry

The recent EU ban on animal testing for cosmetic purposes has laid down the gauntlet for cosmetic companies to find suitable alternatives to test their products. In silico methods provide the best hope for feasible alternatives to maintain the development of new products without impacting on the welfare of animals. 

Pharmaceutical Industry

An overall declining research pipeline, rise in anti-microbial resistance coupled with a huge spike in the cost of research in recent years are a cause of concern for the pharmaceutical industry. 

read more

Non-Commercial Research and Academic Institutions

Research has turned into a truly competitive environment, where heterogeneous interests heavily interfere with the strategic decisions on what should or should not be funded. The VPH Institute focuses on ensuring that in silico medicine research receives an adequate level of funding, by advising the European Commission on the creation of a policy and regulatory framework that is favourable to the adoption of in silico medicine. Your support as a member of the VPH Institute will not only be instrumental in contributing to the transformation of current biomedical research, but it may also improve the quality and the scope of your own R&D and expand your funding base.

Interested to join the VPH Institute?
Find out more information on VPHi website


Interested in
 Avicenna Alliance?

To find out more about how the Avicenna Alliance could benefit your industry, email Thierry Marchal:

Contact us

Avicenna Alliance news

French focus on digital health provides a positive sign for the upcoming French Presidency! 

France will take over the EU presidency of the Council in January of 2022, opening the door for new and...

find out more ›

EU research ministers call for a global approach to research & innovation! 

On the morning of Tuesday 28 September, the EU ministers responsible for research gathered for a Competitiveness...

find out more ›

In Silico in Innovation – again!

The European Innovation Council (EIC) has released its second wave of “start-up champions” to receive funding for innovations through the EIC Accelerator. The EIC...

find out more ›

Avicenna Alliance meets with MEPs to discuss in silico medicine

On 7 October, Dr. Liesbet Geris (Research Professor in Biomechanics and Computational Tissue Engineering at the Universities of Liège &...

find out more ›

The Joint Research Centre advocates for a “paradigm change” to in silico research methods!

For the second week in a row, the Joint Research Centre (JRC) – part of the European Commission’s EU Science...

find out more ›

The European Commission Joint Research Centre publishes a public knowledge base of non-animal models used in immuno-oncology

The Joint Research Centre (JRC), which is part of the European...

find out more ›

The State of the (European) Union

On 15 September, Commission President Ursula von der Leyen delivered her second State of the Union speech at the European Parliament in Strasbourg. She took stock of...

find out more ›

The BECA Beat 

The European Parliament’s Special Committee on Beating Cancer (BECA) met for the first time in September of 2020. BECA was established to create actionable recommendations for Member...

find out more ›

Avicenna Alliance prepares for the next EU policy session 

As September begins, politicians have returned to their EU posts and are preparing for what will be a busy few months for health policy. The...

find out more ›

Joint Research Centre of the Commission launches report on national strategies for Artificial Intelligence!

The Joint Research Centre of the European Commission (JRC) recently published a new report...

find out more ›

Conference of the Slovenian Council Presidency addresses digital twin technologies and digitalisation in healthcare!

On 15 and 16 July, the Slovenian Presidency of the Council of the European Union ...

find out more ›

WHO issues first global report on use of AI in healthcare

Artificial Intelligence (AI) applications in health innovation are rapidly increasing, reflecting the potential of these technologies to...

find out more ›

Slovenian Presidency of the Council of the EU launches its six-month programme!

On 1 July, for the second time since joining the EU in 2004, Slovenia has taken over the Presidency of the Council of...

find out more ›

Members of the European Parliament call EU Health Commissioner to place in silico medicine on her policy agenda from 2021 onwards!

On 22 June, a group of five Members of the European Parliament...

find out more ›

Our new position paper on in silico evidence in the regulatory approval of medical devices is out!

The Avicenna Alliance is proud to announce the recent publication of its new position paper...

find out more ›

Happy 5th Anniversary to the Avicenna Alliance!  

5 years ago, based on the very enlightening Avicenna Roadmap Project Report, the Avicenna Alliance was established at the suggestion of European...

find out more ›

EU New Medical Device Regulation now in force! In silico mentioned for the first time

After a one-year postponement following the COVID-19 pandemic, the European Commission’s Medical Devices...

find out more ›

The European Commission adopts Communication on Europe's global approach to cooperation in research and innovation

On 18 May, the European Commission adopted a Communication on its global approach...

find out more ›

Avicenna Alliance provides feedback on the European Commissions’ roadmap for the revision of the EU general pharmaceuticals legislation

On 27 April, the Avicenna Alliance has submitted its feedback...

find out more ›

Show all activites

Sign up for our monthly newsletter!


Sign up